Navigation Links
Mylan Announces U.S. PTO Intends to Reissue Two Perforomist® Patents to Dey Pharma
Date:8/2/2011

BASKING RIDGE, N.J., Aug. 2, 2011 /PRNewswire/ -- Dey Pharma L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), today announced that the U.S. Patent and Trademark Office intends to reissue both of the patents related to Perforomist® (formoterol fumarate) Inhalation Solution 20 mcg/2mL vial that had been placed into reexamination by Sepracor, now known as Sunovion Pharmaceuticals. Including the two expected reissued patents, Dey believes that seven U.S. patents are infringed by Sunovion's Brovana® product. In addition, Dey believes that Teva's formotorol fumarate product pending before the FDA also infringes several of Dey's U.S. patents. The terms of the patents protecting Perforomist® extend into 2021.

Mylan Chairman and CEO Robert J. Coury commented: "We are very pleased with today's decision by the U.S. PTO in relation to intellectual property protecting Perforomist®, as well as our combination product for the treatment of Chronic Obstructive Pulmonary Disease (COPD), currently in development. We look forward to continuing to assert our very strong IP related to these products in the pending patent litigations against Sunovion and Teva. Today's developments further strengthen the potential of the Dey franchise and its portfolio of products."

About Dey Pharma

Dey Pharma, L.P., a subsidiary of Mylan Inc. (Nasdaq: MYL), is a specialty pharmaceutical company focused on the development, manufacturing and marketing of prescription drug products for the treatment of respiratory diseases, severe allergic reactions and psychiatric disorders. The company puts patients first and facilitates efficient, cost-effective partnerships with customers. For more information, please visit www.dey.com.

About Mylan

Mylan Inc.
'/>"/>

SOURCE Mylan Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Launches First Generic Version of Entocort EC® Capsules
2. Mylan Receives Approval for Generic Version of Aricept® Tablets
3. Mylan Receives Approval for Generic Version of Effexor XR® Capsules
4. Mylan Launches Generic Version of Roxicodone® Tablets
5. Mylan Launches Generic Version of Depakote® Sprinkle Capsules
6. Mylan Launches First Generic Version of Xibrom® Ophthalmic Solution
7. Mylan Launches First Generic Version of Amrix® Capsules
8. Mylan Launches Generic Version of Risperdal® M-Tab®
9. Mylan Launches First Generic Version of Femara® Tablets
10. Mylan Launches Generic Version of Famvir® Tablets
11. Mylan Receives Approval for Generic Version of Xalatan® Ophthalmic Solution
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... -- Hutchison China MediTech Limited ("Chi-Med") ... ("HMP"), its drug R&D subsidiary, successfully achieved the ... of fruquintinib in patients with advanced non-squamous non-small ... .  The top-line results demonstrated that the ... endpoint of progression free survival ("PFS"). ...
(Date:9/3/2015)... With a population of more than 1 ... also its single largest potential market for goods and ... all major world economies in the average rate of ... health expenditures. As an in vitro diagnostics (IVD) market, ... United States, western European countries, and Japan. China represents ...
(Date:9/3/2015)... NEW YORK , Sept. 3, 2015 ... successfully used to save millions of lives across globe. ... the Kingdom of Saudi Arabia . ... raw material suppliers, government agencies and regulatory bodies. The ... been studied from two perspectives: by products and by ...
Breaking Medicine Technology:Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3IVD in China 2IVD in China 3IVD in China 4IVD in China 5IVD in China 6IVD in China 7IVD in China 8IVD in China 9IVD in China 10IVD in China 11IVD in China 12IVD in China 13Saudi Arabia Defibrillators Market: & Advanced Life Support Defibrillators; End Users; Industry Analysis, Size, Volume, Growth, Trends and Forecast 2014 - 2020 2
... 15, 2012 For the 35 million people ... new, fast, effective approach to treatment is now ... light, radiofrequency and ultrasound aesthetic and medical devices, ... newest innovation for the Harmony(XL) multi-application, multi-technology platform, ...
... BARCELONA, Spain, March 15, 2012 Grifols (MCE:GRF, MCE:GRF.P ... largest plasma product manufacturer and a pioneer in the ... to both scientific and social development, has acquired 51% ... the viability of its projects and the future of ...
Cached Medicine Technology:New Nail Fungus Approach Receives FDA Clearance 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 2Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 3Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 4Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 5Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 6Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 7Grifols has Acquired 51% of the Capital of Araclon Biotech to Ensure the Viability of the Purchased Company Projects 8
(Date:9/5/2015)... ... ... a cyber nightmare come to life in the privacy of one’s own home can be ... back helplessly as a hacker took control over their digital world, as reported this ... the whole situation that much more jarring to the senses for the family, they should ...
(Date:9/4/2015)... ... September 05, 2015 , ... Paradise Valley Community College (PVCC) ... one-night exhibition of their work at Paradise Valley Community College. , PVCC Fine and ... 6-9 pm. The artists will be on hand to meet the public and discuss ...
(Date:9/4/2015)... ... ... According to an article published August 18th on Neurology Advisor, ... force that is great enough to cause a traumatic brain injury. This new polymer, ... coaches or officials would instantly see if a player may have suffered a head ...
(Date:9/4/2015)... ... 04, 2015 , ... On the heels of highly successful ... of its annual health tech innovation program. Now featuring a two-phase health tech ... for cash and prizes to advance their technologies toward commercialization, the newly expanded ...
(Date:9/4/2015)... ... ... Mile High Connects today releases “First and Last Mile Connections,” a groundbreaking report ... and other vital supports severely limit access to public transportation for many users. , ... public transit, there’s very little support for safe and convenient access to the transit ...
Breaking Medicine News(10 mins):Health News:IT Security Beware: A Cyber Security Nightmare at Work Can Start at Home 2Health News:IT Security Beware: A Cyber Security Nightmare at Work Can Start at Home 3Health News:IT Security Beware: A Cyber Security Nightmare at Work Can Start at Home 4Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:New Article on Head Injury Detection Technology Highlights Implications for Head Injury Detection in Sports, says The Law Offices of Burg & Brock 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 2Health News:Insight Product Development Startup Competition on Track to Double Program Impact 3Health News:Missed Connections in Metro Denver Transit 2
... are currently testing the safety of hypothermia as ... Hypothermia treatment has been shown to be effective ... its effectiveness in treating children with traumatic brain ... inflammation, excitotoxicity (excessive neurotransmitters released with injury that ...
... it has been shown through previous research studies that the ... cause damage to DNA that triggers cancer. However, it has ... others to melanoma. Researchers have now found out through a ... those with fair skin// have lowered DNA repair capacity and ...
... or Seasonal Affective Disorder(SAD) is not all that well ... lack of sunlight in the winter months. Winter depression ... as the days get longer and nights get shorter. ... foods, and sleeping for longer than usual. Researchers have ...
... recently received a patient, a two-month-old baby with white blood! ... disease caused due to a deficiency of lipoprotein lipase. This ... Doctors said that the baby was brought to the hospital ... a boy child, was found to have lipemic blood. Doctors ...
... ultraviolet rays, has always been said to be bad for one's ... moderate sun exposure can result in moles that may develop into ... been shown as the main risk factor for skin cancer, but ... skin cancer, is much weaker. It has however, been found that ...
... Dutch researchers has stated that there is a metabolic ... daily physical activity becomes deleterious for lumbar bone mineral ... researchers, over a 10-year period, investigated the longitudinal relationship ... and 241 women. They assessed LMBD, habitual daily physical ...
Cached Medicine News:
The ImagingPlanet 80 mm surgical microscope video adapter: superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Leica surgical...
The ImagingPlanet 80 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 80 mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 55 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 55mm focal length adapter an excellent decision for use with your Zeiss surgical micro...
The ImagingPlanet 70 mm Surgical Microscope Adapter. Superior optical quality and precise engineering make this 70 mm focal length adapter an excellent decision for use with your Leica surgical micr...
Medicine Products: